Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Takaaki ONO, MD PhD, Naoto Takahashi, MD PhD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD

Blood (2019) 134 (Supplement_1): 4149.

https://doi.org/10.1182/blood-2019-122092

Published: 2019

Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof

Blood (2019) 134 (Supplement_1): 4285.

https://doi.org/10.1182/blood-2019-122673

Published: 2019

Journal Articles

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

Luke Mountjoy, DO, Daniel Almquist, MD, Henry Ofori, Pharm D, RPh, Marlene Girardo, MS, Margaret McCallen, Pharm D, RPh

Blood (2019) 134 (Supplement_1): 3262.

https://doi.org/10.1182/blood-2019-128644

Published: 2019

Journal Articles

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Jeffrey I. Weitz, MD, Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MD, Theodore E. Spiro, MD, Yoriko De Sanctis, MS, Jianfeng Xu, PhD, Eunyoung Suh, PhD, Wentao Lu, PhD, Concetta Lipardi, MDPhD, Elliot S. Barnathan, MD

Blood (2018) 132 (Supplement 1): 1236.

https://doi.org/10.1182/blood-2018-99-111911

Published: 2018

Journal Articles

Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study

Anastasia Tsagianni, MD, Margaret V. Ragni, MD MPH, Diane M. Comer, BS, Jonathan G. Yabes, PhD

Blood (2018) 132 (Supplement 1): 1179.

https://doi.org/10.1182/blood-2018-99-111731

Published: 2018

Journal Articles

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

Marie Piel-Julian, Matthieu Mahévas, Johanne Germain, Laetitia Languille, Thibault Comont, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Prudhomme, Laurent Sailler, Maryse Lapeyre-Mestre, Nicolas Limal, Odile Beyne-Rauzy, Marc Michel, Daniel Adoue, Bertrand Godeau, Guillaume Moulis, MD

Blood (2017) 130 (Supplement 1): 1041.

https://doi.org/10.1182/blood.V130.Suppl_1.1041.1041

Published: 2017

Journal Articles

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Henrik Gregersen, MD, Niels Abildgaard, MD, Trung Hieu Do, MD, Ida Bruun Kristensen, MD, Ulf Christian Frølund, MD, Niels Frost Andersen, MD, Lene Kongsgaard Nielsen, MD, Christen Lykkegaard Andersen, MD, Tobias Wirenfeldt Klausen, M.S., Annette Juul Vangsted, MD

Blood (2017) 130 (Supplement 1): 3129.

https://doi.org/10.1182/blood.V130.Suppl_1.3129.3129

Published: 2017

Journal Articles

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Todd E. DeFor, MS, Chap Le, PhD, Angela R Smith, MD MS, Erica D. Warlick, MD, Nelli Bejanyan, MD, Daniel J. Weisdorf, MD

Blood (2016) 128 (22): 1167.

https://doi.org/10.1182/blood.V128.22.1167.1167

Published: 2016

Journal Articles

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Yanli Li, MD PhD, Leila Family, PhD, Lie Hong Chen, DrPH, John H. Page, MD ScD, Zandra K. Klippel, MD, Lanfang Xu, PhD, Chun Chao, PhD

Blood (2016) 128 (22): 4797.

https://doi.org/10.1182/blood.V128.22.4797.4797

Published: 2016

Journal Articles

Impact of Comorbidities at Diagnosis of Acute Myeloid Leukemia on One-Year Mortality

Mohamed L Sorror, MD MSc, Barry E. Storer, PhD, Mahmoud Elsawy, MD MSc, Amir T Fathi, MD, Andrew Brunner, MD, Aaron T. Gerds, MD MS, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD, Bruno C. Medeiros, MD, Paul Shami, MD, Esteban Peña, MD, Shylo Wardyn, MS, Jennifer Whitten, MPH, Hannah Frenkel, BS, Jeannine McCune, PharmD, Stephanie J. Lee, MD MPH, Elihu H. Estey, MD

Blood (2015) 126 (23): 532.

https://doi.org/10.1182/blood.V126.23.532.532

Published: 2015

Journal Articles

the Charlson Comorbidity Index Predicts Survival Following Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients

Osamu Imataki, Shumpei Uchida, Maki Oku, Shigeyuki Yokokura, Makiko Uemura, Norimitsu Kadowaki, MD PhD

Blood (2015) 126 (23): 5146.

https://doi.org/10.1182/blood.V126.23.5146.5146

Published: 2015

Journal Articles

External Validation of a Risk Assesment Model for Bleeding Risk in Medical Patients: Findings from the Improve Investigators in a Tertiary Health System

Annie Press, David Rosenberg, MD MPH, Joanna Fishbein, Franak Batliwalla, MPH, Alex C. Spyropoulos, MD

Blood (2015) 126 (23): 748.

https://doi.org/10.1182/blood.V126.23.748.748

Published: 2015

Journal Articles

Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease

Sonikpreet Sonikpreet, Gulshan Oberoi, Sarwan Kumar

Blood (2014) 124 (21): 4869.

https://doi.org/10.1182/blood.V124.21.4869.4869

Published: 2014

Journal Articles

Management of Major Bleeding Caused By Rivaroxaban and the Use of Desmopressin

Ahmad Jajeh, MDMPH

Blood (2014) 124 (21): 5099.

https://doi.org/10.1182/blood.V124.21.5099.5099

Published: 2014

Journal Articles

Conventional Oral Prednisone Versus High-Dose Dexamethasone for Management of Adult Immune Thrombocytopenia: A Prospective Randomized Multicenter Clinical Trial

Yu Wei, Xuebin Ji, Jingxia Wang, Enqin Yang, Zhengcheng Wang, Yuqi Sang, Zuomu Bi, Cuiai Ren, Fang Zhou, Guoqiang Liu, Xin Wang, Jun Peng, Ming Hou, MD

Blood (2014) 124 (21): 1455.

https://doi.org/10.1182/blood.V124.21.1455.1455

Published: 2014

Journal Articles

The Prognostic Impact of Comorbidity in Peripheral T-Cell Lymphomas: a Swedish Lymphoma Registry Study

Fredrik Ellin, MD, Jenny Landström, Mats Jerkeman, MD PhD, Thomas Relander

Blood (2014) 124 (21): 1635.

https://doi.org/10.1182/blood.V124.21.1635.1635

Published: 2014

Journal Articles

Prognostic Impact Of Comorbidity In Multiple Myeloma

Rafael Ríos Tamayo, Joaquín Martínez López, Manuel Jurado, María Esther Clavero Sánchez, Fátima López Jiménez, María Liz Paciello Coronel, José Ramón García Fernández, Youssef Moatassim de la Torre, Francisco López Berenguel, Rosario Leyva Ferrer, Juan Sáinz Pérez, Elena Molina Portillo, María José Sánchez Pérez, José María de Pablos Gallego, Pilar López Garrido, José Juan Jiménez Moleón, Amaia López de Lacalle, Juan José Lahuerta Palacios

Blood (2013) 122 (21): 5340.

https://doi.org/10.1182/blood.V122.21.5340.5340

Published: 2013

Journal Articles

Development and Preliminary Testing Of The Post-Transplant Multimorbidity Index (PTMI)

Sandra A. Mitchell, PhD, CRNP, Steven Z. Pavletic, MD, Ernst Holler, MD, PhD, Philipp Y. Herzberg, PhD, Pia Heussner, MD, Hildegard T Greinix, Bernhard Banas, MD, Daniel Wolff, MD, PhD

Blood (2013) 122 (21): 2076.

https://doi.org/10.1182/blood.V122.21.2076.2076

Published: 2013

Journal Articles

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Sanaz Nicky Soltani, MD, Ramaprasad Srinivasan, MD, PhD, Theresa Jerussi, PAc, A. John Barrett, Thomas E Hughes, PharmD, BCOP, Catalina Ramos, RN, BSN, Lisa Cook, RN, BSN, Elena Cho, RN, MSN, Richard W. Childs, MD

Blood (2013) 122 (21): 4624.

https://doi.org/10.1182/blood.V122.21.4624.4624

Published: 2013

Journal Articles

Characteristics of Patients with Chronic Myelogenous Leukemia in Chronic Phase Switched to Nilotinib or Dasatinib As Second-Line Therapy

Alexander R. Macalalad, MD, Lei Chen, MD PhD, Annie Guerin, MSc, Jiayuan Luo, MSc, Eric Qiong Wu, PhD, James D. Griffin, MD

Blood (2012) 120 (21): 4447.

https://doi.org/10.1182/blood.V120.21.4447.4447

Published: 2012

NARROW

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Impact of Comorbidities at Diagnosis of Acute Myeloid Leukemia on One-Year Mortality

the Charlson Comorbidity Index Predicts Survival Following Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients

External Validation of a Risk Assesment Model for Bleeding Risk in Medical Patients: Findings from the Improve Investigators in a Tertiary Health System

Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease

Management of Major Bleeding Caused By Rivaroxaban and the Use of Desmopressin

Conventional Oral Prednisone Versus High-Dose Dexamethasone for Management of Adult Immune Thrombocytopenia: A Prospective Randomized Multicenter Clinical Trial

The Prognostic Impact of Comorbidity in Peripheral T-Cell Lymphomas: a Swedish Lymphoma Registry Study

Prognostic Impact Of Comorbidity In Multiple Myeloma

Development and Preliminary Testing Of The Post-Transplant Multimorbidity Index (PTMI)

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Characteristics of Patients with Chronic Myelogenous Leukemia in Chronic Phase Switched to Nilotinib or Dasatinib As Second-Line Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only